Seasonal allergic rhinitis
Conditions
Interventions
Experimental Group:Xiangju tablets
Sponsors
Inner Mongolia Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Age between 18 years old to 65 years old, gender is not limite; (2) Meet the diagnostic criteria for seasonal allergic rhinitis (refer to the Chinese Guidelines for the Diagnosis and Treatment of Allergic Rhinitis (Revised Edition 2022)), and meet all of the following conditions on a random day: ? Symptoms: Symptoms such as paroxysmal sneezing, watery rhinorrhea, nasal itching, and nasal congestion occur 2 or more times, and the symptoms last or accumulate for more than 1 hour every day, and may be accompanied by eye symptoms such as tearing, itchy eyes, and red eyes; ? Signs: Nasal mucosa is commonly pale, edematous, and watery nasal secretions;
Exclusion criteria
Exclusion criteria: (1) Combined with severe nasal septal deviation, nasal polyps, sinusitis, hypertrophic rhinitis and other organic nasal diseases, or large-scale trauma to the nasal cavity; (2) Combined with various types of asthma such as bronchial asthma and cough variant asthma; (3) Combined with serious diseases of the heart, brain, liver, kidney, respiratory system, circulatory system, endocrine system, immune system, hematopoietic system and other major organs or systems (such as acute myocardial infarction, malignant tumor, tuberculosis, severe hypertension, diabetic ketosis Diabetic complications such as acidosis, immunodeficiency diseases such as HIV, autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, leukemia, etc.); (4) Pregnant or lactating women, or unwilling to take effective contraceptive measures during the trial; (5) Have a history of allergy to the ingredients of the experimental drugs; (6) Have a history of any disease that affects regimen compliance (such as severe mental disorder, cognitive dysfunction, drug abuse or addiction, long-term alcoholism, etc.); (7) Participated in clinical trials of other drugs or medical devices in the past month; (8) The researcher believes that it is not suitable to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nasal symptom score (TNSS) ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Eye symptom score (TOSS);Nasal/eye single symptom scores;Overall nasal/eye symptom score and single symptom score-time AUC;Time to improve overall and single nasal/eye symptoms;Improvement rate of overall and single nasal/eye symptoms;Time for nasal/eye symptoms and single symptoms to disappear;Disappearance rate of nasal/eye symptom and single symptom scores;Local sign score (anterior rhinoscopy); | — |
Countries
China
Contacts
Public ContactHuang Yan
Inner Mongolia Hospital of Traditional Chinese Medicine
Outcome results
None listed